Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

ZwickRoell Supports Testing of Personal Protective Equipment (PPE) and Primary Packaging for COVID-19 Vaccines

COVID-19 has a big impact on our daily lives and has changed the landscape of the medical and pharmaceutical industries.

25 Sep 2020

Melt Flow Testing Supports the Fight Against Covid-19

ZwickRoell is proud to support the production of PPE through easy-to-use and reliable testing instruments.

25 Sep 2020

ZwickRoell’s zwickiLine Testing System Validated for Cleanroom Use

The importance of cleanrooms is currently in the spotlight as the global community awaits a vaccine for Covid-19.

25 Sep 2020

D614G mutation now the dominant variant in the global COVID-19 pandemic

Now, a new study published on the preprint server medRxiv in September 2020 shows that a significant variant characterized by the D614G mutation has higher infectivity, which may account for its rapid rise to the dominant position in all regions where it has emerged.

25 Sep 2020

Study: Carriers of genetic mutations have greater risk of illness and death from COVID-19

Tel Aviv University researchers suggest that carriers of the genetic mutations PiZ and PiS are at high risk for severe illness and even death from COVID-19. These mutations lead to deficiency in the alpha1-antitrypsin protein, which protects lung tissues from damage in case of severe infections.

25 Sep 2020

About 10% patients with severe disease create auto-antibodies that attack the immune system

People infected by the novel coronavirus can have symptoms that range from mild to deadly. Now, two new analyses suggest that some life-threatening cases can be traced to weak spots in patients' immune systems.

25 Sep 2020

Inflammation in the eye after COVID-19

A new study published on the preprint server medRxiv shows the occurrence of ocular pathology in the period of recovery following COVID-19. This throws more light on the occurrence of inflammation in people recovering from COVID-19.

25 Sep 2020

BIOCAD to produce liquid vaccine for COVID-19 treatment

Clinical trials of the vaccine are currently underway. The &laquoSputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a new adenovirus.

25 Sep 2020

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new research shows. Another 3.5 percent, at least, carry a specific kind of genetic mutation.

25 Sep 2020

New studies report specific mechanisms of impaired type I interferon signaling in COVID-19 patients

Two new studies report specific mechanisms of impaired type I interferon (IFN) signaling in some hospitalized patients suffering from severe cases of COVID-19, suggesting that screens for these defects could help identify patients at the highest risk of life-threatening complications from SARS-CoV-2 infection.

25 Sep 2020

Individuals with severe forms of COVID-19 disease can have compromised type I interferon responses

Individuals with severe forms of COVID-19 disease can present with compromised type I interferon (IFN) responses based on their genetics, according to results published in two papers today in the journal Science.

25 Sep 2020

New experiments reveal how viruses initiate translation of genetic material into proteins

Infectious viruses come in many shapes and sizes and use slightly different attack mechanisms to make humans and animals sick.

25 Sep 2020

New study may explain why more men than women die from COVID-19

New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease.

25 Sep 2020

Berlin researchers are pursuing the development of passive vaccination

Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination.

25 Sep 2020

Talc and non-absorptive creams provide long-lasting skin protection for PPE wearers

For frontline healthcare workers during the COVID-19 pandemic, wearing personal protective equipment (PPE) like face visors, googles, and respiratory protective equipment is an essential part of working life.

25 Sep 2020

Human-to-cat transmission of SARS-CoV-2 confirmed

Cat-to-cat transmission of SARS-CoV-2 has been experimentally proven, but little is known about the significance of this novel virus as a feline pathogen or its reverse zoonotic potential. The establishment of new animal reservoirs of SARS-CoV-2 could pose serious problems for human health in the future.

24 Sep 2020

India and Denmark to benefit from NTNU COVID-19 tests

A highly sensitive COVID-19 test, developed by researchers from the Norwegian University of Science and Technology (NTNU), relies on magnetic nanoparticles to extract viral RNA.

24 Sep 2020

A possible inverse relationship between Dengue and COVID-19 in Brazil

Their study titled, “How super-spreader cities, highways, hospital bed availability, and dengue fever influenced the COVID-19 epidemic in Brazil,” was released pre-peer review on the preprint medRxiv* early this week.

24 Sep 2020

Experimental cancer drug AR-12 inhibits SARS-CoV-2 virus

Nine months into the global pandemic, which has infected more than 32 million people, there is still no approved effective and safe drug or vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

24 Sep 2020

Linoleic acid binds SARS-CoV-2 spike protein

Now, a team of researchers at the Max Planck-Bristol Center for Minimal Biology and Bristol's School of Biochemistry has identified a druggable pocket in the virus's spike protein that can be used to prevent the infection of cells. The study findings, published in the journal Science, are a groundbreaking discovery that will help develop new therapies and drugs to stem the growing pandemic.

24 Sep 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

ZwickRoell Supports Testing of Personal Protective Equipment (PPE) and Primary Packaging for COVID-19 Vaccines

Melt Flow Testing Supports the Fight Against Covid-19

ZwickRoell’s zwickiLine Testing System Validated for Cleanroom Use

D614G mutation now the dominant variant in the global COVID-19 pandemic

Study: Carriers of genetic mutations have greater risk of illness and death from COVID-19

About 10% patients with severe disease create auto-antibodies that attack the immune system

Inflammation in the eye after COVID-19

BIOCAD to produce liquid vaccine for COVID-19 treatment

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

New studies report specific mechanisms of impaired type I interferon signaling in COVID-19 patients

Individuals with severe forms of COVID-19 disease can have compromised type I interferon responses

New experiments reveal how viruses initiate translation of genetic material into proteins

New study may explain why more men than women die from COVID-19

Berlin researchers are pursuing the development of passive vaccination

Talc and non-absorptive creams provide long-lasting skin protection for PPE wearers

Human-to-cat transmission of SARS-CoV-2 confirmed

India and Denmark to benefit from NTNU COVID-19 tests

A possible inverse relationship between Dengue and COVID-19 in Brazil

Experimental cancer drug AR-12 inhibits SARS-CoV-2 virus

Linoleic acid binds SARS-CoV-2 spike protein

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in